These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11366211)

  • 1. Urine test could become early detection device.
    AIDS Alert; 1999 Mar; 14(3):26-7. PubMed ID: 11366211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic detection of human immunodeficincy virus type-1 antibodies in urine, Jimma Hospital, south west Ethiopa.
    Taye B; Woldeamanuel Y; Kebede E
    Ethiop Med J; 2006 Oct; 44(4):363-8. PubMed ID: 17370436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine test finds HIV when blood test can't.
    Newsline People AIDS Coalit N Y; 1999 Jan; ():35. PubMed ID: 11367191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of very early antibody to native HIV antigens by HIV neutralization and live-cell immunofluorescence assays.
    Pan J; Chen J; Lee H; Sahu GK; Poast JS; Tyring S; Cloyd M; Baron S
    Antiviral Res; 2006 Jun; 70(2):21-7. PubMed ID: 16513186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
    Hare CB; Pappalardo BL; Busch MP; Karlsson AC; Phelps BH; Alexander SS; Bentsen C; Ramstead CA; Nixon DF; Levy JA; Hecht FM
    Clin Infect Dis; 2006 Mar; 42(5):700-8. PubMed ID: 16447118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state of HIV/AIDS in Taiwan and reappraisal of early diagnostic value of serial and comparative analyses of western blot patterns of HIV infection.
    Chen MY; Chuang CY
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():39-46. PubMed ID: 11890112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary IgG antibody capture particles adherence test for detecting HIV antibodies: a preliminary report.
    Muralidharan S; Srinivasa H; Ravindran GD; Nobbay B
    J Assoc Physicians India; 1998 Aug; 46(8):699-700. PubMed ID: 11229276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.
    Adalid-Peralta L; Grangeot-Keros L; Rudent A; Ngo-Giang-Huong N; Krzysiek R; Goujard C; Deveau C; Le Gall M; Meyer L; Emilie D; Rouzioux C
    HIV Med; 2006 Nov; 7(8):514-9. PubMed ID: 17105510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies present in urine may not be detected in blood.
    AIDS Policy Law; 1998 Dec; 13(22):7. PubMed ID: 11366055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA antibodies to human immunodeficiency virus in serum, saliva and urine for early diagnosis of immunodeficiency virus infection in Ugandan infants.
    Morgado de Moura Machedo JE; Kayita J; Bakaki P; Coulter JB; Ndugwa CM; Tindyebwa D; Hart CA
    Pediatr Infect Dis J; 2003 Feb; 22(2):193-5. PubMed ID: 12613456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients.
    Söderlund J; Hirbod T; Goh LE; Andersson J; Broliden K
    Scand J Infect Dis; 2004; 36(9):663-9. PubMed ID: 15370653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
    Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Solinas P; Mannazzu M; Falchi A; Mura MS; Madeddu G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):375-83. PubMed ID: 16584508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine test.
    AIDS Policy Law; 1996 Aug; 11(15):12. PubMed ID: 11363733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.